Urinary Problems in Women

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 53-71

  French, Linda ^a   Phelps, Kevin ^a   Pothula, Nageswar Rao ^a   Mushkbar, Saudia ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Neighborhood Health Clinic   (United States)

Author keywords

Interstitial cystitis; Irritable bladder; Overactive bladder; Painful bladder syndrome; Urinary incontinence; Urinary symptoms; Urinary tract infection; Women

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANESTHETIC AGENT; BOTULINUM TOXIN A; CEFALEXIN; CEFTRIAXONE; CIMETIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; DARIFENACIN; DULOXETINE; GABAPENTIN; GENTAMICIN; HEPARIN; HYDROXYZINE; NITROFURANTOIN; NOREPHEDRINE; NORFLOXACIN; NORTRIPTYLINE; OFLOXACIN; OXYBUTYNIN; PENTOSAN POLYSULFATE; PREDNISONE; SOLIFENACIN; TOLTERODINE; TOPIRAMATE; TRIMETHOPRIM; TROSPIUM CHLORIDE; UNINDEXED DRUG;

ACUPUNCTURE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BEDTIME DOSAGE; BODY MASS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CYSTALGIA; DEPRESSION; DIABETES MELLITUS; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DYSURIA; FOOD INTAKE; FORCEPS DELIVERY; HEALTH CARE COST; HUMAN; HYSTERECTOMY; INTERSTITIAL CYSTITIS; LIFESTYLE MODIFICATION; MULTIPARA; OVERACTIVE BLADDER; PATHOGENESIS; PATHOPHYSIOLOGY; PELVIC FLOOR MUSCLE TRAINING; PELVIC ORGAN PROLAPSE; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; RISK FACTOR; SEXUALITY; SMOKING; SMOKING CESSATION; STRESS INCONTINENCE; TREATMENT DURATION; URGE INCONTINENCE; URINALYSIS; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY URGENCY; URINE CULTURE; URINE INCONTINENCE; UROGENITAL TRACT DISEASE; VAGINA FLORA; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-BACTERIAL AGENTS; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; RECURRENCE; RISK FACTORS; URINARY INCONTINENCE; URINARY TRACT INFECTIONS; WOMEN'S HEALTH;

EID: 60249093861     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.003     Document Type: Review

References (108)

1. Schappert S.M. Ambulatory care visits to physician offices, hospital outpatient department, and emergency departments: United States, 1997. Vital Health Stat 13 (1999) 1-39 i-iv
2. Rosenberg M. Pharmacoeconomics of treating uncomplicated urinary tract infections. Int J Antimicrob Agents 11 3-4 (1999) 247-251 [discussion 261-4]
3. Foxman B., Barlow R., D'Arcy H., et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10 8 (2000) 509-515
4. Hooton T.M., Scholes D., Hughes J.P., et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335 7 (1996) 468-474
5. Moreno E., Andreu A., Perez T., et al. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 134 5 (2006) 1015-1023
6. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 Suppl 1A (2002) 14S-19S
7. Gupta K., Scholes D., and Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281 8 (1999) 736-738
8. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182 4 (2000) 1177-1182
9. Hooton T.M., Hillier S., Johnson C., et al. Escherichia coli bacteriuria and contraceptive method. JAMA 265 1 (1991) 64-69
10. Sheinfeld J., Schaeffer A.J., Cordon-Cardo C., et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 320 12 (1989) 773-777
11. Perrotta C., Aznar M., Mejia R., et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database of Systematic Reviews (Online) 2 (2008) :CD005131
12. Moore E.E., Jackson S.L., Boyko E.J., et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol 111 2 Pt 1 (2008) 317-323
13. Bent S., Nallamothu B.K., Simel D.L., et al. Does this woman have an acute uncomplicated urinary tract infection?. JAMA 287 20 (2002) 2701-2710
14. Hurlbut III T.A., and Littenberg B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol 96 5 (1991) 582-588
15. Sultana R.V., Zalstein S., Cameron P., et al. Dipstick urinalysis and the accuracy of the clinical diagnosis of urinary tract infection. J Emerg Med 20 1 (2001) 13-19
16. Fenwick E.A., Briggs A.H., and Hawke C.I. Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract 50 457 (2000) 635-639
17. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ 332 7533 (2006) 94-97
18. Kunin C.M., White L.V., and Hua T.H. A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms. Ann Intern Med 119 6 (1993) 454-460
19. Papanicolaou N., and Pfister R.C. Acute renal infections. Radiol Clin North Am 34 5 (1996) 965-995
20. Johnson J.R., Vincent L.M., Wang K., et al. Renal ultrasonographic correlates of acute pyelonephritis. Clin Infect Dis 14 1 (1992) 15-22
21. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29 4 (1999) 745-758
22. Anderson V.R., and Perry C.M. Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs 66 6 (2006) 821-835
23. Kahan N.R., Chinitz D.P., Waitman D., et al. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?. Ann Pharmacother 40 12 (2006) 2223-2227
24. Nicolle L., Anderson P.A.M., and Conly J. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician 52 (2006) 612-618
25. Gupta K., Hooton T.M., Roberts P.L., et al. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 167 20 (2007) 2207-2212
26. Hooton T.M., Winter C., Tiu F., et al. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 273 1 (1995) 41-45
27. Gupta K., Hooton T.M., and Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135 1 (2001) 41-50
28. Manges A.R., Johnson J.R., Foxman B., et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 345 14 (2001) 1007-1013
29. Pinson A.G., Philbrick J.T., Lindbeck G.H., et al. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med 12 3 (1994) 271-278
30. Lowe F.C., and Fagelman E. Cranberry juice and urinary tract infections: what is the evidence?. Urology 57 3 (2001) 407-413
31. Stapleton A., Latham R.H., Johnson C., et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 264 6 (1990) 703-706
32. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 113 Suppl 1A (2002) 80S-84S
33. Dean N.M., Ellis G., Wilson P.D., et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 3 (2006) :CD002239
34. Moehrer B., Hextall A., and Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2 (2003) :CD001405
35. Gibbs C.F., Johnson II T.M., Ouslander J.G., et al. Office management of geriatric urinary incontinence. Am J Med 120 3 (2007) 211-220
36. Nygaard I., Turvey C., Burns T.L., et al. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol 101 1 (2003) 149-156
37. Melville J.L., Newton K., Fan M.Y., et al. Health care discussions and treatment for urinary incontinence in U.S. women. Am J Obstet Gynecol 194 3 (2006) 729-737
38. Hannestad Y.S., Rortveit G., and Hunskaar S. Help-seeking and associated factors in female urinary incontinence. The Norwegian EPINCONT Study. Epidemiology of Incontinence in the County of Nord-Trondelag. Scand J Prim Health Care 20 2 (2002) 102-107
39. Ricci J.A., Baggish J.S., Hunt T.L., et al. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther 23 8 (2001) 1245-1259
40. Roberts R.O., Jacobsen S.J., Rhodes T., et al. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc 46 4 (1998) 467-472
41. Stoddart H., Donovan J., Whitley E., et al. Urinary incontinence in older people in the community: a neglected problem?. Br J Gen Pract 51 468 (2001) 548-552
42. Kinchen K., Bump R., and JR.Gobier. Prevalence and frequency of stress urinary incontinence among community- dwelling women. Eur Urol 1 1 (2002) 85
43. Hunskaar S., Burgio K., Diokno A., et al. Epidemiology and natural history of urinary incontinence. In: Abrams P., et al. (Ed). Incontinence: 2nd International Consultation on Incontinence, July 1-3, 2001 (2002), Health Publication Ltd., Plymouth (UK) 165-201
44. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 46 4 (1998) 473-480
45. Wilson L., Brown J.S., Shin G.P., et al. Annual direct cost of urinary incontinence. Obstet Gynecol 98 3 (2001) 398-406
46. Subak L.L., Brown J.S., Kraus S.R., et al. The "costs" of urinary incontinence for women. Obstet Gynecol 107 4 (2006) 908-916
47. Holroyd-Leduc J.M., and Straus S.E. Management of urinary incontinence in women: clinical applications. JAMA 291 8 (2004) 996-999
48. Barker L.R., Burton J.R., and Zieve P.D. Principles of ambulatory medicine. 6th edition. (2003), Lippincott Williams & Wilkins, Philadelphia
49. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21 2 (2002) 167-178
50. Culligan P.J., and Heit M. Urinary incontinence in women: evaluation and management. Am Fam Physician 62 11 (2000) 2433-44, 2447, 2452
51. Holroyd-Leduc J.M., Tannenbaum C., Thorpe K.E., et al. What type of urinary incontinence does this woman have?. JAMA 299 12 (2008) 1446-1456
52. Bradley C.S., Rovner E.S., Morgan M.A., et al. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol 192 1 (2005) 66-73
53. Brown J.S., Bradley C.S., Subak L.L., et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med 144 10 (2006) 715-723
54. Urinary incontinence in women. Obstet Gynecol 105 6 (2005) 1533-1545
55. Nice. The management of urinary incontinence in women. Available at: (2006). www.nice.org.uk/Guidance/CG40 [cited]. Accessed August 27, 2008
56. Fantl J, Newman D, Colling J. Urinary incontinence in adults: acute and chronic management. 1996: Rockville, MD.
57. McKertich K. Urinary incontinence-assessment in women: stress, urge or both?. Aust Fam Physician 37 3 (2008) 112-117
58. Weidner A.C., Myers E.R., Visco A.G., et al. Which women with stress incontinence require urodynamic evaluation?. Am J Obstet Gynecol 184 2 (2001) 20-27
59. Nygaard I.E., and Heit M. Stress urinary incontinence. Obstet Gynecol 104 3 (2004) 607-620
60. Hannestad Y.S., Rortveit G., Daltveit A.K., et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 110 3 (2003) 247-254
61. Subak L.L., Whitcomb E., Shen H., et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol 174 1 (2005) 190-195
62. Wilson P., Bo K., and Hay-Smith J. Conservative treatment in women. In: Abrams P., et al. (Ed). Incontinence (2002), Health Publication Ltd, Plymouth UK 823-826
63. Hay-Smith E.J., and Dumoulin C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 1 (2006) :CD005654
64. Bo K., Kvarstein B., and Nygaard I. Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol 105 5 Pt 1 (2005) 999-1005
65. Shamliyan T, Wyman J, Bliss DZ, et al. Prevention of urinary and fecal incontinence in adults. Evid Rep Technol Assess 2007;161:27-35.
66. Norton P.A., Zinner N.R., Yalcin I., et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187 1 (2002) 40-48
67. Bump R.C., Norton P.A., Zinner N.R., et al. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol 102 1 (2003) 76-83
68. Grady D., Brown J.S., Vittinghoff E., et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97 1 (2001) 116-120
69. Nygaard I.E., and Kreder K.J. Pharmacologic therapy of lower urinary tract dysfunction. Clin Obstet Gynecol 47 1 (2004) 83-92
70. Farrell S.A., Baydock S., Amir B., et al. Effectiveness of a new self-positioning pessary for the management of urinary incontinence in women. Am J Obstet Gynecol 196 5 (2007) 474 e1-8
71. Leach G.E., Dmochowski R.R., Appell R.A., et al. Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol 158 3 Pt 1 (1997) 875-880
72. Jelovsek J.E., Barber M.D., Karram M.M., et al. Randomised trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-term follow up. BJOG 115 2 (2008) 219-225 [discussion 225]
73. Liapis A., Bakas P., and Creatsas G. Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct 19 11 (2008) 1509-1512
74. Robert M., Ross S., Farrel S.A., et al. Conservative management of urinary incontinence. J Obstet Gynaecol Can 28 12 (2006) 1113-1125
75. Halaska M., Ralph G., Wiedemann A., et al. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 20 6 (2003) 392-399
76. Madersbacher H., Stohrer M., Richter R., et al. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia. Br J Urol 75 4 (1995) 452-456
77. Haab F, Halasaka M, Klaver M. Favorable efficacy and tolerability with long-term solifenacin treatment support high patient persistence. In: Annual Meeting of the International Continence Society. 2004, August 25-27. Paris France.
78. Epstein B.J., Gums J.G., and Molina E. Newer agents for the management of overactive bladder. Am Fam Physician 74 12 (2006) 2061-2068
79. Cappellano F., Bertapelle P., Spinelli M., et al. Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166 6 (2001) 2277-2280
80. Schmid D.M., Sauermann P., Werner M., et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 1 (2006) 177-185
81. Emmons S.L., and Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol 106 1 (2005) 138-143
82. Kelada E., and Jones A. Interstitial cystitis. Arch Gynecol Obstet 275 4 (2007) 223-229
83. van de Merwe J.P., Nordling J., Bouchelouche P., et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53 1 (2008) 60-67
84. Clemens J.Q., Meenan R.T., Rosetti M.C., et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol 173 1 (2005) 98-102 [discussion 102]
85. Parsons J.K., Kurth K., and Sant G.R. Epidemiologic issues in interstitial cystitis. Urology 69 4 Suppl (2007) 5-8
86. Driscoll A., and Teichman J.M. How do patients with interstitial cystitis present?. J Urol 166 6 (2001) 2118-2120
87. Clemens J.Q., Meenan R.T., O'Keeffe R., et al. Costs of interstitial cystitis in a managed care population. Urology 71 5 (2008) 776-780 [discussion 780-1]
88. Parsons C.L. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69 4 Suppl (2007) 9-16
89. Sant G.R., Kempuraj D., Marchand J.E., et al. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69 4 Suppl (2007) 34-40
90. Nazif O., Teichman J.M.H., and Gebhart G.F. Neural upregulation in interstitial cystitis. Urology 69 4 Suppl (2007) 24-33
91. Wesselmann U. Interstitial cystitis: a chronic visceral pain syndrome. Urology 57 6 Suppl 1 (2001) 32-39
92. Evans R.J., and Sant G.R. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology 69 4 Suppl (2007) 64-72
93. van de Merwe J.P. Interstitial cystitis and systemic autoimmune diseases. Nature Clinical Practice. Urology 4 9 (2007) 484-491
94. Parsons C.L., Dell J., Stanford E.J., et al. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol 187 5 (2002) 1395-1400
95. Shorter B., Lesser M., Moldwin R.M., et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol 178 1 (2007) 145-152
96. Teichman J.M.H., and Parsons C.L. Contemporary clinical presentation of interstitial cystitis. Urology 69 4 Suppl (2007) 41-47
97. Moldwin R.M., Evans R.J., Stanford E.J., et al. Rational approaches to the treatment of patients with interstitial cystitis. Urology 69 4 Suppl (2007) 73-81
98. Thilagarajah R., Witherow R.O., and Walker M.M. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 87 3 (2001) 207-212
99. Davis E.L., El Khoudary S.R., Talbott E.O., et al. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179 1 (2008) 177-185
100. Porru D., Cervigni M., Nasta L., et al. Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of interstitial cystitis/painful bladder syndrome. Rev Recent Clin Trials 3 2 (2008) 126-129
101. Peters K.M., Feber K.M., and Bennett R.C. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int 100 4 (2007) 835-839
102. Anger J.T., Saigal C.S., and Litwin M.S. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 175 2 (2006) 601-604
103. Kuh D., Cardozo L., and Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health 53 8 (1999) 453-458
104. Parazzini F., Chiaffarino F., Lavezzari M., et al. Risk factors for stress, urge or mixed urinary incontinence in Italy. BJOG 110 10 (2003) 927-933
105. Bump R.C., and McClish D.K. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol 167 5 (1992) 1213-1218
106. Larsen W.I., and Yavorek T.A. Pelvic organ prolapse and urinary incontinence in nulliparous women at the United States Military Academy. Int Urogynecol J Pelvic Floor Dysfunct 17 3 (2006) 208-210
107. Jackson S.L., Scholes D., Boyko E.J., et al. Urinary incontinence and diabetes in postmenopausal women. Diabetes Care 28 7 (2005) 1730-1738
108. Zorn B.H., Montgomery H., Pieper K., et al. Urinary incontinence and depression. J Urol 162 1 (1999) 82-84